Paragon Private Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
3,545
+2
+0.1% +$234 0.12% 156
2026
Q1
$426K Buy
3,543
+302
+9% +$34.9K 0.13% 154
2025
Q4
$341K Buy
3,241
+170
+6% +$16K 0.1% 167
2025
Q3
$258K Buy
+3,071
New +$253K 0.08% 196

Other funds holding MRK

Paragon Private Wealth Management's MRK Position: Q2 2026 in Review

Paragon Private Wealth Management increased its Merck (MRK) stake by 0.06% in Q2 2026, buying an estimated $234 and bringing the position to 3,545 shares worth $455K. The position accounts for 0.12% of the portfolio, ranked #156.

Paragon Private Wealth Management first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Paragon Private Wealth Management held 3,545 shares of Merck worth $455K as of Q2 2026.
  • Paragon Private Wealth Management bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.12% of Paragon Private Wealth Management's portfolio in Q2 2026, its #156 holding.
  • Paragon Private Wealth Management first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.